Approval · Notice of Compliance 17441 · 2015
CYDECTIN: Notice of Compliance 17441
Issued November 5, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17441
- Date
- November 5, 2015
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYDECTIN | 02298899 | Cancelled Pre Market |
Medicinal ingredients
- MOXIDECTIN 10 PER per WAF